IPCA LABS Plunges by 6%; BSE HEALTHCARE Index Down 1.5%
May 13, 2019 12:16 PM

IPCA LABS share price has plunged 6% and is presently trading at Rs 974.

Meanwhile, the BSE HEALTHCARE Index is at 13,801 (down 1.5%).

Among the top losers in the BSE HEALTHCARE Index today is IPCA LABS (down 5.6%).

BLISS GVS PHARMA (up 1.5%) and GRANULES INDIA (up 0.9%) are among the top gainers today.

Over the last one year, IPCA LABS has moved up from Rs 726 to Rs 974, registering a gain of Rs 247 (up 34.0%)..

The BSE HEALTHCARE has moved up from 13,474 to 13,801, registering a gain of 327 points (up 2.4%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DR. REDDYS LAB (up 42.9%), SUVEN LIFESCIENCES (up 41.2%) and DIVIS LABORATORIES (up 37.9%).

What About the Benchmark Indices?

The BSE Sensex is at 37,584 (down 0.1%). The top gainers among the BSE Sensex stocks today are HUL (up 0.8%). The most traded stocks in the BSE Sensex are SBI and ITC.

In the meantime, NSE Nifty is at 11,300 (down 0.2%). TITAN (up 1.2%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,246 to 37,584, registering a gain of 2,338 points (up 6.2%).

IPCA LABS Financial Update...

IPCA LABS net profit stood at Rs 2 billion for the quarter ended December 2018, compared to a profit of Rs 1 billion a year ago. Net Sales rose 10.3% to Rs 9.5 billion during the period as against Rs 8.6 billion in October-December 2017.

For the year ended March 2018, IPCA LABS reported 23.1% increase in net profit to Rs 2.4 billion compared to net profit of Rs 1.9 billion during FY17.

Revenue of the company grew 2.2% to Rs 33 billion during FY18.

The current Price to earnings ratio of IPCA LABS, based on rolling 12 month earnings, stands at 29.2x.